Pds biotech to participate at b. riley securities precision oncology & radiopharma conference 2025

Princeton, n.j., feb. 20, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that frank bedu-addo, phd, president and chief executive officer of pds biotech will participate in a fireside chat at the b.
PDSB Ratings Summary
PDSB Quant Ranking